Recent Finacing
Recent Raise
ProteinQure develops AI-driven peptide therapeutics using its ProteinStudio platform—combining machine learning, structural and atomic-level simulations—to design non‑natural amino acid peptides for tissue‑specific delivery across oncology, neurology, and nephrology programs.
